BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹711 Cr | ₹644 Cr | ₹653 Cr | ₹504 Cr | ₹544 Cr |
What is the latest Net Current Assets ratio of BLISS GVS PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹711 Cr |
| Mar2025 | ₹644 Cr |
| Mar2024 | ₹653 Cr |
| Mar2023 | ₹504 Cr |
| Mar2022 | ₹544 Cr |
How is Net Current Assets of BLISS GVS PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹711 Cr | 10.29 | |
| Mar2025 | ₹644 Cr | -1.37 | |
| Mar2024 | ₹653 Cr | 29.63 | |
| Mar2023 | ₹504 Cr | -7.29 | |
| Mar2022 | ₹544 Cr | - | |
Compare Net Current Assets of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹5,534.1 Cr | 6.6% | 23% | 234.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 6.6% |
23% |
234.6% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses